Fmoc-His-Aib-OH is a protected dipeptide building block used in solid-phase peptide synthesis. It consists of an N-terminal Fmoc-protected histidine linked to an alpha-methylalanine (Aib) residue, which introduces conformational constraints into peptide sequences.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1446013-07-5
N-Boc-4-hydroxy-D-proline, trans-
Peptide synthesis intermediate
(2S)-2-{[(tert-butoxy)carbonyl]amino}pentanedioic acid
Peptide synthesis intermediate
FMOC-DAB(Z)-OH
Peptide synthesis intermediate
L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-
Peptide synthesis intermediate
2-(1-(1-Methylethyl)-1H-pyrazol-5-yl)-3-pyridinemethanol
voxelotor synthetic intermediate
3-(chloromethyl)-2-(1-isopropyl-1H-pyrazol-5-yl)pyridine hydrochloride
pharmaceutical intermediate synthesis
6-(6-(Trifluoromethyl)pyridin-2-yl)-1,3,5-triazine-2,4(1H,3H)-dione
pharmaceutical intermediate
Tert-Butyl 2-cyanopyrrolidine-1-carboxylate
Pharmaceutical intermediate for pyrrolidine derivatives
2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoic acid
DRXNKOXLDLFGEG-NRFANRHFSA-N
CC(C)(C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24